Takeda's net profit plunges 24% as Prevacid slumps
This article was originally published in Scrip
Executive Summary
The negative trends of the first quarter continued through to Takeda's results for the first half ended 30 September, when total net sales at Japan's largest pharmaceutical company fell by 5% to ¥714.0 billion ($8.78 billion).